Glenmark Pharmaceuticals, an India-based drug manufacturer has issued a voluntary recall affecting nearly 1.48 million bottles of atomoxetine, a generic medication used to treat ADHD.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
